Nationwide Fund Advisors - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 89 filers reported holding GW PHARMACEUTICALS PLC in Q4 2014. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2015$2,010,000
-25.6%
22,0000.0%0.01%
-18.2%
Q2 2015$2,702,000
+19.1%
22,000
-11.6%
0.01%
+22.2%
Q1 2015$2,269,000
+34.7%
24,9000.0%0.01%
+28.6%
Q4 2014$1,685,000
-17.6%
24,900
-1.6%
0.01%
-22.2%
Q3 2014$2,046,000
-29.1%
25,300
-5.9%
0.01%
-25.0%
Q2 2014$2,886,000
+80.7%
26,9000.0%0.01%
+71.4%
Q1 2014$1,597,00026,9000.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2014
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders